JKA: Tubes, Vials, Systems, Serum Separators, Blood Collection

Product code JKA, “Tubes, Vials, Systems, Serum Separators, Blood Collection” in FDA's classification database, is a Class II device type under 21 CFR 862.1675 (blood specimen collection device), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 238 clearances under JKA, 74 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
JKA
Regulation
21 CFR 862.1675
Class
II
Panel
Clinical Chemistry
Clearances
238
Most recent
Oct 16, 2026
Median review, last 2 years
143 days
Third-party review
Not eligible
Implant
No

What it covers

A blood specimen collection device is a device intended for medical purposes to collect and to handle blood specimens and to separate serum from nonserum (cellular) components prior to further testing. This generic type device may include blood collection tubes, vials, systems, serum separators, blood collection trays, or vacuum sample tubes.

The identification in 21 CFR 862.1675, blood specimen collection device. FDA gives JKA no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K252344BD Vacutainer® Serum Blood Collection Tubes; BD Vacutainer® Rapid Serum Tubes (RST)Becton, Dickinson and CompanyOct 16, 2026Traditional
K262215Profoject™ Safety Sliding Blood Collection SetCMT Health PTE., Ltd.Sep 25, 2026Traditional
K252899Female Culture Device; Male Culture Device; Transfer Device; Access DeviceZhejiang Kindly Medical Device Co., Ltd.Jun 2, 2026Traditional
K260128BD Preset™ and BD A-Line™ Arterial Blood Collection SyringesBecton, Dickinson and CompanyApr 15, 2026Special
K252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre-Attached HolderBecton, Dickinson and CompanyApr 10, 2026Traditional
K252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood Collection TubeBecton, Dickinson and CompanyApr 10, 2026Traditional
K252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection TubesBecton, Dickinson and CompanyMar 13, 2026Traditional
K251812Steripath® Flow™ Blood Collection SystemMagnolia Medical TechnologiesSep 25, 2025Traditional
K243207BD Vacutainer® Eclipse™ Blood Collection NeedleBecton, Dickinson and CompanyJul 3, 2025Traditional
K250961Blood collection tube holdersPromisemed Hangzhou Meditech Co., Ltd.Jun 4, 2025Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 238 with a free account)

Clearances by year

74 JKA 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)7254
20257115
20246240
202316198
20229164
20214217
20206181
20196181
20181264
20172128
20164116
2015190
20141390
20133244
20121314

Who submits

36 applicants cleared a JKA device since 2011. 69% of the clearances went to applicants in United States, then China (18%), Japan (5%) and Singapore (5%). By type: Traditional 89% and Special 11%. 1 went through a third-party review organization.

ApplicantClearances since 2011
Becton, Dickinson and Company19
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd.4
Velano Vascular4
Kurin, Inc.3
Nsp Tech Pte, Ltd.3
Sb-Kawasumi Laboratories, Inc.3
Sol-Millennium Medical, Inc.3
Becton Dickinson Infusion Therapy Systems, Inc.2

How FDA classifies it

Class II.

From 21 CFR 862.1675.

Standards

21 CFR 862.1675 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent JKA clearances declared.

Ask about JKA

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about JKA

What is FDA product code JKA?

Product code JKA, “Tubes, Vials, Systems, Serum Separators, Blood Collection” in FDA's classification database, is a Class II device type under 21 CFR 862.1675 (blood specimen collection device), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 238 clearances under JKA, 74 of them since 2011.

How many 510(k) clearances are there under JKA?

FDA’s 510(k) database listed 238 clearances under JKA as of Oct 29, 2026, 74 of them decided since 2011; the most recent decision was Oct 16, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a JKA 510(k)?

For the 15 JKA clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 143 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most JKA clearances?

Since 2011: Becton, Dickinson and Company (19), Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. (4), Velano Vascular (4), Kurin, Inc. (3) and Nsp Tech Pte, Ltd. (3). 36 applicants have cleared a JKA device in that time.

Sources

  1. FDA product classification: JKA · Product Classification database
  2. 21 CFR 862.1675: Blood specimen collection device · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for JKA · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow JKAGet an email when FDA clears, recalls or publishes guidance for JKA devices.

Know what FDA already cleared.